| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
49 companies · Health Care
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Sep 19, 2025 | NTRA Natera, Inc. | Sheena Jonathan | Director, Co-founder | Sell | 13,690 | $178.65 | $2,445,695.76 | -2.1% | |
| Sep 18, 2025 | NTRA Natera, Inc. | Rabinowitz Matthew | Executive Chairman | Sell | 24,473 | $180.08 | $4,407,069.25 | -1.0% | |
| Sep 18, 2025 | BDSX Biodesix Inc | Schuler Jack W | - | Buy | 18,373 | $6.06 | $111,425.34 | +0.7% | |
| Sep 17, 2025 | AWHL Aspira Women's Health Inc. | Schuler Jack W | 10% Owner | Buy | 1,111,111 | $0.45 | $499,999.95 | +41.0% | |
| Sep 17, 2025 | AWHL Aspira Women's Health Inc. | Cohen Jeffrey K | Director | Buy | 55,556 | $0.45 | $25,000.20 | +17.4% | |
| Sep 17, 2025 | AWHL Aspira Women's Health Inc. | Fraser John D | Director | Buy | 16,389 | $0.45 | $7,375.05 | +3.0% | |
| Sep 17, 2025 | CSTL Castle Biosciences Inc | Maetzold Derek J | Pres. &Chief Exec. Officer | Sell | 1,339 | $21.97 | $29,419.17 | -2.0% | |
| Sep 17, 2025 | GH Guardant Health, Inc. | Tariq Musa | Director | Sell | 116 | $55.63 | $6,453.08 | -1.5% | |
| Sep 17, 2025 | GH Guardant Health, Inc. | Potter Myrtle S | Director | Sell | 26 | $55.63 | $1,446.38 | -0.1% | |
| Sep 16, 2025 | WGS Genedx Holdings Corp. | Stueland Katherine | Chief Executive Officer | Sell | 10,501 | $121.47 | $1,275,584.82 | -41.9% | |
| Sep 16, 2025 | RDNT Radnet, Inc. | Stolper Mark | EVP, Chief Financial Officer | Sell | 35,000 | $73.89 | $2,586,150.00 | -34.0% | |
| Sep 16, 2025 | WGS Genedx Holdings Corp. | Feeley Kevin | Chief Financial Officer | Sell | 3,728 | $121.47 | $452,850.23 | -29.9% | |
| Sep 16, 2025 | RDNT Radnet, Inc. | Katz David Jeffrey | EVP And Chief Legal Officer | Sell | 14,000 | $74.44 | $1,042,160.00 | -17.0% | |
| Sep 15, 2025 | TWST Twist Bioscience Corp | Cho Dennis | See Remarks | Sell | 94 | $25.33 | $2,380.83 | - | |
| Sep 12, 2025 | NTRA Natera, Inc. | Rabinowitz Matthew | Executive Chairman | Sell | 5,000 | $170.54 | $852,707.35 | -9.0% | |
| Sep 12, 2025 | GH Guardant Health, Inc. | Hidalgo Medina Manuel | Director | Sell | 2,165 | $54.16 | $117,250.77 | -71.8% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.